Traditional Chinese Medicine Market to Witness Higher CAGR

The traditional Chinese medicine market is likely to grow to a sassy level shortly. Chabot powered by machine learning is transforming the way patient interaction happens. Machine learning is there to help radiologists identify differences in scans. This, in turn, helps them diagnose and detect health problems, that too, at an early stage. This is the current trend in the healthcare industry and the status quo is expected to remain unchanged even in the future.

Traditional Chinese Medicine is one of the oldest health and wellness systems used in China for thousands of years. Other medications focus primarily on treating an illness. But traditional Chinese medicines aim to increase immune power and aim for overall well-being. The most common type of traditional Chinese medicine includes herbal products, acupuncture, and Tai Chi, among others.

Get a sample copy of this report @

According to a latest report published by PMR, the global traditional Chinese medicine market is expected to grow at a CAGR of over 5% over the forecast period (2022-2030).

Company Profiles:

Zhongxin Pharmaceuticals
Tianjin Tasly Group
Yuannan Baiyao
Solstice Medicine Company, Inc.
Shanghai Sundise Traditional Chinese Medicine Co.,Ltd
China Chinese Medicine Holding Co., Ltd.
Hunan goldliloo pharmaceutical Co.,Ltd
Wanbang Pharma Group Corp.
Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
Pfizer Inc.
Eli Lilly and company
Novartis AG
GlaxoSmithKline PLC
Mallinckrodt Pharmaceuticals
Hisamitsu Pharmaceutical Co., Inc.

Methodology [email protected]

Key Findings from Traditional Chinese Medicine Market Research

Non-traditional Chinese medicines are the leading segment by product in the global traditional Chinese medicine market. The Autism Spectrum Disorder (ASD) segment has gained popularity in recent years and is expected to grow at a rate of 6.7% over the forecast period.
North America is the leading region in the traditional Chinese medicine market, followed by Europe.
East and South Asia, including China, South Korea, Japan, India and ASEAN countries, is the fastest growing region in the medicine market Chinese tradition, due to improved medical infrastructure.
Tong Ren Tang, Pfizer, and Novartis AG are some of the major players in the global traditional Chinese medicine market. These companies invest most of their revenue in R&D and focus on strengthening their distribution channels to maintain a leading position in the traditional Chinese medicine market.
More than 100 health systems are partnering with retail chains, providing physician oversight and increasing patient traffic to retail clinics, and extending health system networks to new patient populations .
The COVID-19 pandemic is a cause for concern, which has deprioritized non-essential medical treatments. This will hurt the growth of the global traditional Chinese medicine market in the short term.

“Rising incidence of ADHD to drive growth of global traditional Chinese medicine market,” says PMR analyst.

Access the full [email protected]

The increasing prevalence of ADHD is a major factor contributing to the growth of Traditional Chinese Medicine market revenue across the globe. The exact cause of ADHD is still unclear, although a genetic influence is seen in most cases.

According to data released by the Centers for Disease Control and Prevention (CDC), about 6.1 million (9.4%) – 388,000 children aged 2 to 5, 4 million children aged 6 to 11 and 3 million children ages 12 to 17 – have been diagnosed with ADHD in the United States. In Spain, the combined prevalence of ADHD in a population of 361,580 children and adolescents was estimated at 6.8% over the last decade.

The prevalence of ADHD is increasing at an alarming rate, which is expected to fuel revenue growth for ADHD therapies such as traditional Chinese medicines, as there is no specific treatment for this disorder.

Full report [email protected]

Product Innovation – Key Strategy of Traditional Chinese Medicine Market Players

Major players in the global traditional Chinese medicine market are introducing innovative products to retain their market share. A patented technology called Oral Osmotic Controlled Release System (OROS) is used in Concerta, manufactured by Johnson & Johnson. It releases an initial dose of methylphenidate within the first two hours of ingestion, and as the pill passes through the stomach and gastrointestinal tract, water is absorbed, causing internal pressure, which releases small amounts of medicine when the pill passes through the intestine. This technology has been implemented to maintain the consistency of cognitive performance enhancement throughout the day.

What does the report cover?

Persistence Market Research offers a unique perspective and actionable insights into the Traditional Chinese Medicine market in its latest study, presenting a historical demand assessment from 2015 to 2019 and projections for 2020 to 2030, based on product (drugs traditional Chinese (TCM) and non-traditional Chinese (non-TCM) medicines) and indication (autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD)), across seven key regions.

Related reports:

Medical Implant Sterile Packaging Market –

Polycystic Ovary Syndrome Drugs Market –

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York, NY 10007 USA
Telephone in the United States – +1-646-568-7751
USA-Canada Toll Free – +1 800-961-0353
Sales – [email protected]
Website –

About Us:

Persistence Market Research is here to provide businesses with a one stop solution when it comes to improving customer experience. It is committed to gathering appropriate feedback after going through personalized customer interactions to add value to the customer experience by acting as the “missing” link between “customer relationships” and “business results”. The best possible returns are guaranteed.

This press release was published on openPR.

Comments are closed.